Neuren Pharmaceuticals | Capitaux Propres Et Réserves



Equity Capital And Reserves Changement Date
Alaunos Therapeutics USD 2.06M 661K 2024-12
Avita Medical AUD 4.5M 19.42M 2024-12
Clinuvel Pharmaceuticals AUD 203.01M 24.36M 2024-06
Dianthus Therapeutics USD 352.48M 14.58M 2024-12
Genetic Signatures AUD 54.59M 6.51M 2024-12
Ionis Pharmaceuticals USD 475.73M 112.62M 2025-03
Medical Developments International AUD 55.33M 9.6M 2024-12
Neuren Pharmaceuticals AUD 363.9M 144.75M 2024-12
Organon & Co USD 542M 70M 2025-03
Paradigm Biopharmaceuticals AUD 34.06M 10.25M 2024-12
PYC Therapeutics AUD 55.44M 25.62M 2024-12
Starpharma Holdings AUD 23.17M 4.94M 2024-12
Tectonic Therapeutic USD 140.78M 9.58M 2024-12
Telix Pharmaceuticals AUD 568.21M 164.24M 2024-12
Viatris USD 15.65B 2.99B 2025-03
Xeris Pharmaceuticals USD -29615000 1.29M 2024-12



Neuren Pharmaceuticals Capitaux Propres Et Réserves - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Jun 2025.